Sosei, Itochu Forge Alliance in Biopharmaceutical Business

Japanese biopharmaceutical company Sosei has announced that it has agreed with trading giant Itochu to form a strategic partnership. Specifically, Itochu will acquire 2 percent of Sosei's outstanding shares in early March. Through the move, the trading company will make a full entry into the biopharmaceutical business. Meanwhile, Sosei aims to boost its R&D pipeline by leveraging Itochu's expertise in the biotech field.

Japan Corporate News (http://www.japancorp.net/Article.Asp?Art_ID=9564)